Plasmodium SEY1 is a novel druggable target that contributes to imidazolopiperazine mechanism of action
Elizabeth A. Winzeler(University of California San Diego), Francisco‐Javier Gamo(GlaxoSmithKline (France))
Cited by 0
Related Papers
Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics
|Science|2018|273
Common PIEZO1 Allele in African Populations Causes RBC Dehydration and Attenuates Plasmodium Infection
|Cell|2018|262
Antimalarial drug discovery: progress and approaches
|Nature Reviews Drug Discovery|2023|207
Dual RNA-seq identifies human mucosal immunity protein Mucin-13 as a hallmark of Plasmodium exoerythrocytic infection
|Nature Communications|2019|76
Exposure of Plasmodium sporozoites to the intracellular concentration of potassium enhances infectivity and reduces cell passage activity
|Molecular and Biochemical Parasitology|2007|58